Recent Updates
Recently added Catalysts
KPTI Neutral Sentiment Score: 60/100

Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Thursday, February 22, 2024 1 min read
Key Takeaway: Karyopharm Therapeutics Inc. has announced it will report its fourth quarter and full year 2023 financial results on February 29, 2024. A conference call and audio webcast will follow at 8:00 a.m. ET to discuss these financial results along with other company updates. The public can access the call via a designated phone number or through the company's investor website for those who prefer the audio webcast. Archived webcasts will be available shortly after the event.

Market Sentiment Analysis

Full Press Release Details

-- Conference Call Scheduled for Thursday, February 29, 2024, at 8:00 a.m. ET --
NEWTON, Mass., Feb. 22, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2023 financial results on Thursday, February 29, 2024. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, February 29, 2024, to discuss the financial results and other company updates.
To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
SOURCE Karyopharm Therapeutics Inc.

21 %

more press release views with

Frequently Asked Questions

When is the Karyopharm conference call scheduled?

The conference call is scheduled for February 29, 2024, at 8:00 a.m. ET.

How can I access the Karyopharm conference call?

To access the call, dial (800) 836-8184 for local or (646) 357-8785 for international.

Where can I find the webcast of the conference call?

The live webcast will be available in the Investor section on Karyopharm's website.

What financial results will Karyopharm report?

Karyopharm will report its fourth quarter and full year 2023 financial results.

Will an archived version of the call be available?

Yes, an archived version will be available on Karyopharm's website about two hours post-event.

Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm financial results earnings call conference call
Last updated: Feb 22, 2024